NASDAQ:LHCG - LHC Group Stock Price, Forecast & News

LHC Group trades on the NASDAQ under the ticker symbol "LHCG."

LHC Group, Inc. (NASDAQ:LHCG) announced its quarterly earnings results on Wednesday, November, 6th. The health services provider reported $1.26 EPS for the quarter, topping analysts' consensus estimates of $1.08 by $0.18. The health services provider earned $528.50 million during the quarter, compared to analyst estimates of $534.15 million. LHC Group had a net margin of 4.59% and a return on equity of 9.39%. The business's revenue for the quarter was up 4.2% on a year-over-year basis. During the same period in the previous year, the business posted $0.95 earnings per share. View LHC Group's Earnings History.

LHC Group is scheduled to release their next quarterly earnings announcement on Wednesday, February 26th 2020. View Earnings Estimates for LHC Group.

LHC Group issued an update on its FY19 earnings guidance on Wednesday, November, 6th. The company provided earnings per share (EPS) guidance of $4.35-4.45 for the period, compared to the Thomson Reuters consensus estimate of $4.33. The company issued revenue guidance of $2.09-2.14, compared to the consensus revenue estimate of $2.10 billion.

11 Wall Street analysts have issued 1 year target prices for LHC Group's stock. Their forecasts range from $114.00 to $160.00. On average, they anticipate LHC Group's stock price to reach $133.80 in the next twelve months. This suggests that the stock has a possible downside of 6.6%. View Analyst Price Targets for LHC Group.

11 Wall Street analysts have issued "buy," "hold," and "sell" ratings for LHC Group in the last year. There are currently 3 hold ratings and 8 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for LHC Group.

News articles about LHCG stock have been trending very positive on Friday, InfoTrie reports. InfoTrie scores the sentiment of media coverage by analyzing more than six thousand news and blog sources in real-time. The firm ranks coverage of public companies on a scale of negative five to positive five, with scores closest to five being the most favorable. LHC Group earned a media sentiment score of 3.8 on InfoTrie's scale. They also assigned news coverage about the health services provider a news buzz of 0.0 out of 10, meaning that recent media coverage is extremely unlikely to have an impact on the stock's share price in the near future. View News Stories for LHC Group.

LHC Group saw a drop in short interest in December. As of December 13th, there was short interest totalling 1,740,000 shares, a drop of 7.4% from the November 28th total of 1,880,000 shares. Based on an average daily volume of 201,100 shares, the days-to-cover ratio is presently 8.7 days. Currently, 5.8% of the company's stock are sold short. View LHC Group's Current Options Chain.

Some companies that are related to LHC Group include Laboratory Corp. of America (LH), Quest Diagnostics (DGX), Davita (DVA), Chemed (CHE), Amedisys (AMED), AMN Healthcare Services (AMN), BioScrip (BIOS), MEDNAX (MD), CorVel (CRVL), R1 RCM (RCM), Tivity Health (TVTY), The Providence Service (PRSC), Cross Country Healthcare (CCRN) and Interpace Diagnostics Group (IDXG).

Based on aggregate information from My MarketBeat watchlists, some companies that other LHC Group investors own include Home Depot (HD), Verizon Communications (VZ), Cisco Systems (CSCO), Alibaba Group (BABA), Visa (V), CVS Health (CVS), Chevron (CVX), Honeywell International (HON), Johnson & Johnson (JNJ) and Exxon Mobil (XOM).

LHC Group's stock is owned by a number of of retail and institutional investors. Top institutional shareholders include Tributary Capital Management LLC (0.85%), Copper Rock Capital Partners LLC (0.52%), Scout Investments Inc. (0.29%), Calamos Advisors LLC (0.15%), State of Alaska Department of Revenue (0.07%) and Meridian Wealth Management LLC (0.01%). Company insiders that own LHC Group stock include Donald Dwayne Stelly, Jeff Reibel, John L Indest, Joshua L Proffitt, Keith G Myers, Ronald T Nixon and Tyree G Wilburn. View Institutional Ownership Trends for LHC Group.

LHCG stock was sold by a variety of institutional investors in the last quarter, including Tributary Capital Management LLC, Scout Investments Inc., State of Alaska Department of Revenue and Calamos Advisors LLC. Company insiders that have sold LHC Group company stock in the last year include Donald Dwayne Stelly, John L Indest, Joshua L Proffitt, Keith G Myers and Ronald T Nixon. View Insider Buying and Selling for LHC Group.

LHCG stock was bought by a variety of institutional investors in the last quarter, including Copper Rock Capital Partners LLC and Meridian Wealth Management LLC. View Insider Buying and Selling for LHC Group.

Shares of LHCG can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

One share of LHCG stock can currently be purchased for approximately $143.18.

LHC Group has a market capitalization of $4.51 billion and generates $1.81 billion in revenue each year. The health services provider earns $63.57 million in net income (profit) each year or $3.55 on an earnings per share basis. LHC Group employs 30,985 workers across the globe.View Additional Information About LHC Group.

The official website for LHC Group is http://www.lhcgroup.com/.

LHC Group's mailing address is 901 HUGH WALLIS ROAD SOUTH, LAFAYETTE LA, 70508. The health services provider can be reached via phone at 337-233-1307 or via email at [email protected]